Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
ASH 2010: New potential area of treatment for TET2 mutated myeloid malignancies
ASH 2010: New potential area of treatment for TET2 mutated myeloid malignancies
ASH 2010: Nilotinib promising for early chronic phase, Philidelphia-positive chronic myeloid leukaemia
ASH 2010: Nilotinib promising for early chronic phase, Philidelphia-positive chronic myeloid leukaemia
ASH 2010: Imatinib enhances long term outcomes in Philidelphia-positive acute lymphoblastic leukaemia
ASH 2010: Imatinib enhances long term outcomes in Philidelphia-positive acute lymphoblastic leukaemia
The effect of obesity on early-stage breast cancer prognosis
The effect of obesity on early-stage breast cancer prognosis
FDA panel rejects drugs to prevent prostate cancer
FDA panel rejects drugs to prevent prostate cancer
New imaging technique delivers real time optical biopsies
New imaging technique delivers real time optical biopsies
Herceptin to benefit small breast tumours as well
Herceptin to benefit small breast tumours as well
Patients' healthcare-related decisions: feeling informed or being informed?
Patients' healthcare-related decisions: feeling informed or being informed?
Discovery halts breast cancer stem cells
Discovery halts breast cancer stem cells
PARP inhibitor, MK-4827, shows anti-tumour activity in first trial in humans
PARP inhibitor, MK-4827, shows anti-tumour activity in first trial in humans

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation